Aspire Biopharma Holdings, Inc. - Common Stock (ASBP)

CUSIP: 738920107

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
138,530,928
Total 13F shares
6,823,464
Share change
+3,700,421
Total reported value
$899,822
Price per share
$0.13
Number of holders
30
Value change
+$486,842
Number of buys
14
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 738920107?
CUSIP 738920107 identifies ASBP - Aspire Biopharma Holdings, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ASBP - Aspire Biopharma Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Lance Friedman
13D/G
4.5%
2,207,886
$1,037,706 -$782,315 06 May 2025
ARDSLEY ADVISORY PARTNERS LP
13D/G
7.8%
10,750,000
$860,000 $0 31 Dec 2025
Crewe Advisors LLC
13F
Company
0.59%
813,427
$167,566 30 Sep 2025
13F
Procyon Advisors, LLC
13F
Company
0.34%
472,661
$97,368 30 Sep 2025
13F
VANGUARD GROUP INC
13F
Company
0.31%
428,552
$88,281 30 Sep 2025
13F
Harraden Circle Investments, LLC
13D/G
0.31%
150,000
$70,500 $0 31 Mar 2025
Optivise Advisory Services LLC
13F
Company
0.19%
263,522
$54,286 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.18%
250,161
$51,533 30 Sep 2025
13F
Antara Capital LP
13F
Company
mixed-class rows
410,590
mixed-class rows
$48,007 30 Sep 2025
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
class O/S missing
1,050,000
$31,395 30 Sep 2025
13F
Saba Capital Management, L.P.
13F
Company
class O/S missing
983,603
$29,410 30 Sep 2025
13F
LINDEN ADVISORS LP
13F
Company
class O/S missing
899,999
$25,200 30 Sep 2025
13F
VR Advisory Services Ltd
13F
Company
mixed-class rows
197,083
mixed-class rows
$23,044 30 Sep 2025
13F
ARISTEIA CAPITAL, L.L.C.
13F
Company
class O/S missing
681,516
$19,048 30 Sep 2025
13F
Resolute Advisors LLC
13F
Company
0.06%
82,783
$17,053 30 Sep 2025
13F
TORONTO DOMINION BANK
13F
Company
class O/S missing
516,945
$15,508 30 Sep 2025
13F
Three Seasons Wealth, LLC
13F
Company
0.05%
75,000
$15,450 30 Sep 2025
13F
PERISCOPE CAPITAL INC.
13F
Company
mixed-class rows
174,924
mixed-class rows
$14,035 30 Sep 2025
13F
Sculptor Capital LP
13F
Company
class O/S missing
500,000
$13,975 30 Sep 2025
13F
Clear Street Group Inc.
13F
Company
class O/S missing
437,264
$13,074 30 Sep 2025
13F
Verition Fund Management LLC
13F
Company
class O/S missing
432,757
$12,939 30 Sep 2025
13F
P SCHOENFELD ASSET MANAGEMENT LP
13F
Company
0.04%
58,563
$12,064 30 Sep 2025
13F
Avion Wealth
13F
Company
0.04%
54,113
$11,000 30 Sep 2025
13F
BARCLAYS PLC
13F
Company
class O/S missing
350,000
$10,465 30 Sep 2025
13F
Crossingbridge Advisors, LLC
13F
Company
mixed-class rows
74,194
mixed-class rows
$10,218 30 Sep 2025
13F
CIBC Private Wealth Group LLC
13F
Company
0.04%
49,129
$10,121 30 Sep 2025
13F
VALLEY WEALTH MANAGERS, INC.
13F
Company
0.03%
40,000
$8,240 30 Sep 2025
13F
Donald G. Fell
3/4/5
Director
0.01%
20,000
$7,800 $0 04 Jun 2025
Platform Technology Partners
13F
Company
0.03%
37,611
$7,748 30 Sep 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.02%
31,120
$6,411 30 Sep 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.02%
29,257
$6,027 30 Sep 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
class O/S missing
199,999
$5,980 30 Sep 2025
13F
WOLVERINE ASSET MANAGEMENT LLC
13F
Company
class O/S missing
197,144
$5,894 30 Sep 2025
13F
XTX Topco Ltd
13F
Company
0.02%
27,851
$5,737 30 Sep 2025
13F
Context Capital Management, LLC
13F
Company
class O/S missing
175,000
$5,233 30 Sep 2025
13F
Mint Tower Capital Management B.V.
13F
Company
class O/S missing
25,000
$5,000 30 Sep 2025
13F
NOMURA HOLDINGS INC
13F
Company
class O/S missing
150,000
$4,500 30 Sep 2025
13F
Polar Asset Management Partners Inc.
13F
Company
class O/S missing
138,536
$3,879 30 Sep 2025
13F
LMR Partners LLP
13F
Company
class O/S missing
125,000
$3,738 30 Sep 2025
13F
WHITEBOX ADVISORS LLC
13F
Company
class O/S missing
118,750
$3,551 30 Sep 2025
13F
Focus Partners Wealth
13F
Company
0.01%
12,538
$2,583 30 Sep 2025
13F
Allred Capital Management, LLC
13F
Company
0.01%
11,185
$2,304 30 Sep 2025
13F
Limestone Investment Advisors LP
13F
Company
class O/S missing
75,000
$2,243 30 Sep 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
class O/S missing
57,932
$1,732 30 Sep 2025
13F
UBS Group AG
13F
Company
0.01%
7,661
$1,578 30 Sep 2025
13F
Blue Owl Capital Holdings LP
13F
Company
class O/S missing
50,000
$1,495 30 Sep 2025
13F
PICTON MAHONEY ASSET MANAGEMENT
13F
Company
class O/S missing
50,000
$1,000 30 Sep 2025
13F
OMERS ADMINISTRATION Corp
13F
Company
class O/S missing
25,000
$747 30 Sep 2025
13F
SOA Wealth Advisors, LLC.
13F
Company
0%
2,920
$602 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
253
$52 30 Sep 2025
13F

Institutional Holders of Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) as of Q4 2025

As of 31 Dec 2025, Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,823,464 shares. The largest 10 holders included UBS Group AG, Crewe Advisors LLC, JANE STREET GROUP, LLC, VANGUARD GROUP INC, Optivise Advisory Services LLC, XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, LLC, Procyon Advisors, LLC, Antara Capital LP, and Resolute Advisors LLC. This page lists 30 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
25
Q4 2025 holders
30
Holder diff
5
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .